Lv7
3210 积分 2024-05-26 加入
A Ligand‐Based Approach to the Discovery of Lead‐Like Potassium Channel K V 1.3 Inhibitors
5小时前
已完结
Deucravacitinib for the Treatment of Psoriatic Disease
6天前
已完结
Computational insights of deucravacitinib’s selectivity for TYK2 pseudokinase vs. JAK kinase domain via molecular modeling studies
28天前
已完结
Computational insights of deucravacitinib’s selectivity for TYK2 pseudokinase vs. JAK kinase domain via molecular modeling studies
1个月前
已完结
Decoding ligand recognition and constitutive activation of histamine H3 and H4 receptors
1个月前
已完结
Design of PAP-1, a Selective Small Molecule Kv1.3 Blocker, for the Suppression of Effector Memory T Cells in Autoimmune Diseases
3个月前
已完结
Sticking to nooks and crannies
5个月前
已完结
Potassium Channel Block by a Tripartite Complex of Two Cationophilic Ligands and a Potassium Ion
5个月前
已完结
Piperacillin/tazobactam-induced reversible pancytopenia in a pregnant patient: A case report
5个月前
已关闭
Chinese Medicine in the Treatment of Ulcerative Colitis: The Mechanisms of Signaling Pathway Regulations
5个月前
已完结
皖公网安备34019202002308
